Overall rank by patents
#27,782
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 4 technology areas, active 2024–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04B (TRANSMISSION).
The verdict
Virewirx holds 10 US patents across 4 technology areas, rank #27,782 of 50,000 tracked assignees.
Virewirx, Inc. has been granted 10 US utility patents between 2024 and 2025, placing Virewirx, Inc. at rank #27,782 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.2 claims per patent with primary concentration in H04B (TRANSMISSION). As a US Corporation, Virewirx, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Virewirx sits between Via Fortuna, Llc (10 patents, rank #27,778) and Virtual Radiologic Corporation (10 patents, rank #27,786) - the closest US assignees by grant volume. The composite Innovation Score of 46.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2024 through 2025, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Virewirx, Inc.'s 19.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Virewirx, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Via Fortuna, LLC
10 patents
Victory Industrial Corporation
10 patents
Vidrio Plano de México, S.A. de C.V.
10 patents
Viking Therapeutics, Inc.
10 patents
Virgin Instruments Corporation
10 patents
Virginia Polytechnic Institute and State University
10 patents
Viridity Energy, Inc.
10 patents
Virtual Radiologic Corporation
10 patents
Virewirx, Inc.
10 patents
What this shows Virewirx holds 10 patents at rank #27,782, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #27,782 in granted patent volume.
Other assignees with the most granted patents in Virewirx's primary technology class.
Virewirx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 20% higher than 80% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 8 | 80.0% |
| 2025 | 2 | 20.0% |
Top 4 of 4 technology areas
Overall rank by patents
#27,782
Across all tracked assignees
46.9 out of 100
How to use this portfolio
Virewirx's 10 grants land it in the top 20% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.